Count | |
| 10 | |
| 8 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 60 | |
| 43 | |
| 39 | |
| 1 | |
| 1 | |
| 1 | |
| 16 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 7 | |
| 1 | |
| 2 | |
| 23 | |
| 1 | |
| 3 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
Aspirin/administration & dosage/pharmacology/*therapeutic use | 1 |
Aspirin/administration & dosage/*antagonists & inhibitors/pharmacology | 1 |
Aspirin/administration & dosage/analogs & derivatives/pharmacology | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 5 | |
| 4 | |
| 1 | |
| 5 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 10 | |
| 11 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |